Speeches by Craft.

“I thank the hon. Gentleman for his intervention. It is key to recognise the role that farmers can play in rewilding and embracing biodiversity. In Thurrock, there are farmers who are doing excellent work in rewilding some of their land to make sure that species can thrive and continue to grow. It is not only on farmlan…”

“I am grateful to the hon. Lady for mentioning biomass power, as I have a specific issue in my constituency, where the fuel that is used to power a biomass generator has unfortunately generated a significant amount of dust, causing a heavy amount of air pollution in the local area. It is a form of green energy, but it u…”

“It is a pleasure to serve under your chairship, Ms Lewell. I congratulate my hon. Friend the Member for Milton Keynes North (Chris Curtis) on securing the debate. Like many Members, I am a lover of woodlands, both ancient and new. As my hon. Friend the Member for Cannock Chase (Josh Newbury) said earlier, “You can’t ha…”

“The Minister will not have failed to notice the spectacular redwoods at Wakehurst on her visit there. Will she support Forestry England’s measures to make sure that one in five new trees planted are novel species such as the redwood and the cedar, which are predicted to cope much better with changing climate?”

“That leads quite neatly on to my set of questions around vaccine hesitancy. You spoke about the building trust model among healthcare professionals. What are the most significant lessons learned from the covid-19 vaccination programme that you are carrying forward to address vaccine hesitancy and improve public trust?”

“Specifically, how is that addressing hesitancy?”

“What specific measurable accountability metrics do you have to prove that this is successful?”

“Are you specifically tracking areas where you have previously seen levels of vaccine hesitancy to see if some of the misinformation and disinformation is dying down?”

“Briefly, are you measuring hesitancy among health professionals on getting things such as the winter flu vaccine? How are you tackling it?”

“Do you have an example of a programme that has been sustained?”

“I am trying to get around that hesitancy but not necessarily the access, because there are examples of widening access.”

“Can you give me an example of an approach that you have tried? You have evaluated it, it has been successful and has been rolled out. We had a very good example in the first panel of engagement with an Orthodox Jewish community, but there was a cost there.”

“Is there anything in place to monitor levels of disinformation and misinformation on a wider scale, and a strategy to counter that? Community groups are fantastic at a granular, local level, and I appreciate your being able to provide that example. On a wider level, what people are picking up from social media perhaps …”

“The question is how are you tracking what interventions are successful? For example, one learning from the covid-19 pandemic was that behavioural scientists did not use nudge techniques enough. Are you looking at behavioural science? Are you looking at ways to nudge? How are you tracking what works?”

“Access and confidence are two sides of the same coin. Are you tracking which interventions are successful?”

“What is driving that lack of confidence among health professionals? That is another question leading on from my colleague’s question earlier.”

“Jennifer, when you first undertook your programme, what support was available nationally to roll it out?”

“It needs a highly specialist service to do so.”

“I should have said this at the beginning—apologies, Chair. I meant to declare an interest, which is that I chair the all-party parliamentary group on learning disability. Thank you to my colleague here for reminding me about that. What kind of support do you wish would have been available? What would have been more hel…”

“To clarify, one standout thing for me in Baroness Hollins’ report was that there is no therapeutic benefit to long-term segregation. I wanted to make that clear to the Committee as well. The results you have had from HOPE(S), you have said, have been highly successful for patients, professionals and the wider NHS.”